Booster shot shows strong protection against three serious diseases in teens

NCT ID NCT02118961

First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 20 times

Summary

This study tested a booster dose of the DTaP vaccine (BK1301) in 446 adolescents aged 11-12 who had already received the vaccine series as children. The goal was to confirm the booster effectively strengthens immunity against diphtheria, tetanus, and pertussis (whooping cough). Results showed the vaccine triggered strong antibody responses, meeting the study's targets for protection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TETANUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Inverstigational site

    Kumagaya-shi, Saitama, Japan

  • Inverstigational site

    Shinjuku-ku, Tokyo, Japan

  • Investigational site

    Fukuoka, Fukuoka, Japan

  • Investigational site

    Itoshima-shi, Fukuoka, Japan

  • Investigational site

    Kasuga-shi, Fukuoka, Japan

  • Investigational site

    Hiroshima, Hiroshima, Japan

  • Investigational site

    Shizuoka, Shizuoka, Japan

Conditions

Explore the condition pages connected to this study.